"Elderly patients with poor-prognosis diffuse large B-cell lymphoma (DLBCL) may derive the most benefit from treatment with extended rituximab plus 6 cycles of R-CHOP on a 14-day schedule, according to the results of the SMARTE-R study published in the Journal of Clinical Oncology."
Encouraging news with a 3-year overall survival of 84% for all patients
Photo: Some red flowers in the rain on a member of the mint family - Lamiaceae. This plant had my researcher Jay struggling for quite a while before he finally identified the plant. If I'd just crushed one of the leaves, the strong mint smell would have given a very big clue!